Affy Shares Surge 12 Percent One Day After Firm Reported 20-Percent Q4 Revenue Growth | GenomeWeb

NEW YORK, Jan. 27 (GenomeWeb News) - Shares in Affymetrix were up 11.95 percent, or $4.34, at $40.67 in late-afternoon trading today, one day after the company reported substantial gains in revenue during the fourth quarter.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.